May 6, 2021

Hospira recalls one lot each of 0.5% Bupivacaine and 1% Lidocaine because of mislabeling

By: Judy Mathias
Share

Editor's Note

Hospira Inc, a Pfizer company, announced May 4 that it is recalling lot EG6023 of 0.5% Bupivacaine Hydrochloride Injection, USP 30 mL and lot EG8933 of 1% Lidocaine HCL Injection, USP 30 mL because of mislabeling.

A portion of each lot was incorrectly labeled as the other product. The issue was identified by a customer.


Sponsored Message

Use of the impacted products could cause adverse events of moderate to high severity.

Read More >>

Get OR Manager Updates

Sign Up Now
Latest Issue of OR Manager
February 2022
Video Spotlight
Live chat by BoldChat